content

Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received...

Digital Science reports that just 10% of global research output relates to the UN’s Sustainable Development Goals

Digital Science, a leading technology company serving emergent needs across the research sector, has released a report highlighting the growth in research around the...

Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program

Pfizer Inc. and BioNTech SE announced that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the...

Rescheduled CPhI South East Asia to now take place in November 2020

CPhI South East Asia – organised by Informa Markets – has postponed its rescheduled event to November 4-6, 2020 to provide more time for...

AI-based precision medicine mining of UK Biobank finds 13 human COVID risk genes and identifies 59 drugs with potential to improve survival in severe...

Data scientists from UK-headquartered AI precision medicine company, PrecisionLife, have used the Company’s proprietary AI enabled precision medicine platform to identify 59 repurposing drug...

Oliver Healthcare Packaging clinches Packaging Design of the Year Award

Singapore’s Oliver Healthcare Packaging received the Packaging Design of the Year Award at the recently concluded Healthcare Asia Pharma Awards 2020. The award recognised the...

Developed Antibody Against Coronavirus, “Terrific Breakthrough”: Israel

COVID-19 Vaccine: Israeli Defence Minister Naftali Bennett was shown the "antibody that attacks the virus in a monoclonal way and can neutralize it within...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read